Back
Astria Therapeutics, Inc. 10K Form
Sell
48
ATXS
Astria Therapeutics, Inc.
Last Price:
$13.12
Seasonality Move:
28.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATXS News And Ratings
See the #1 stock for the next 7 days that we like better than ATXS
ATXS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-32.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.44 |
| Price / Book: | 5.43 |
Profitability
| EPS (TTM): | -2.15050 |
|---|---|
| Net Income (TTM): | $-124M |
| Gross Margin: | $0 |
| Return on Equity: | -42.95% |
| Return on Assets: | -39.55% |
Astria Therapeutics, Inc. Earnings Forecast
Key Astria Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 12 years have been positive in 8 years.
Astria Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATXS |
| Website: | astriatx.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 10.78 |
| Quick Ratio: | 10.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATXS Technical Analysis vs Fundamental Analysis
Sell
48
Astria Therapeutics, Inc. (ATXS)
is a Sell
Is Astria Therapeutics, Inc. a Buy or a Sell?
-
Astria Therapeutics, Inc. stock is rated a SellThe current Astria Therapeutics, Inc. [ATXS] share price is $13.12. The Score for ATXS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.